A Study to Evaluate the Efficacy and Safety of Toripalimab or Placebo Combined With Chemotherapy in Treatment-naive Advanced NSCLC

NCT03856411 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

465

Enrollment

OTHER

Sponsor class

Conditions

Treatment-naive Advanced Non-small Cell Lung Cancer

Interventions

DRUG: TORIPALIMAB INJECTION (JS001 ) combine with chemotherapy

Sponsor

Shanghai Junshi Bioscience Co., Ltd.